Phosphorous-containing cysteine and serine protease inhibitors

Inhibiteurs de proteases a cysteine et serine, contenant du phosphore

Abstract

La présente invention concerne des inhibiteurs de protéases à cystéine et sérine, contenant du phosphore. L'invention concerne également des procédés d'utilisation de ces inhibiteurs de protéases.
The present invention is directed to novel phosphorous-containing inhibitors of cysteine or serine proteases. Methods for the use of the protease inhibitors are also described.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (0)

    Publication numberPublication dateAssigneeTitle

NO-Patent Citations (5)

    Title
    DATABASE CAPLUS ON STN, Chemical Abstracts Service, (Columbus, Ohio, US), Accession No. 1984:51966, RAMAGE, R. et al., "Application of Phosphinic Acids to Peptide Synthesis"; & PEPT. PROC. EUR. PEPT. SYMP., 17th (1983), Meeting Date 1982, 157-62 (Compound with Registry No. 88577-10-0).
    DATABASE CAPLUS ON STN, Chemical Abstracts Service, (Columbus, Ohio, US), Accession No. 1988:611439, SCHLEMMER, H. et al., "Phosphorus-31 Nuclear Magnetic Resonance Spectroscopy of the Phosphorylated Tetrapeptide Gly-Gly-Asp-Ala"; & MAGN. RESON. CHEM. (1988), 26(3), 260-3 (Compound with Registry No. 117289-76-6).
    DATABASE CAPLUS ON STN, Chemical Abstracts Service, (Columbus, Ohio, US), Accession No. 1995:297974, DOLLE, R.E. et al., "Aspartylalpha-((Diphenylphosphinyl)oxy)met hyl Ketones as Novel Inhibitors of Interleukin-1beta Converting Enzyme. Utility of the Diphenylphosphonic Acid Leaving Group for the Inhibition of
    DATABASE CAPLUS ON STN, Chemical Abstracts Service, (Columbus, Ohio, US), Accession No. 1995:867576, STERLING-WINTHROP, INC., "Preparation of Peptide Derivatives as Interleukin 1beta-Converting Enzyme Inhibitors"; & JP,A,07 025 887, 27 January 1995.
    See also references of EP 0871454A4

Cited By (43)

    Publication numberPublication dateAssigneeTitle
    EP-0938477-A1September 01, 1999Cephalon, Inc.Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
    EP-0938477-A4December 29, 1999Cephalon IncBenzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
    EP-2520654-A1November 07, 2012The Regents of the University of ColoradoInhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
    EP-3192872-A1July 19, 2017The Regents of the University of Colorado, a body corporateInhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
    US-6312662-B1November 06, 2001Metabasis Therapeutics, Inc.Prodrugs phosphorus-containing compounds
    US-6489308-B1December 03, 2002Trustees Of University Of Technology CorporationInhibitors of serine protease activity, methods and compositions for treatment of nitric-oxide-induced clinical conditions
    US-6506733-B1January 14, 2003Axys Pharmaceuticals, Inc.Compounds and compositions as protease inhibitors
    US-6946115-B2September 20, 2005Metabasis Therapeutics, Inc.Prodrugs for phosphorus-containing compounds
    US-6977256-B2December 20, 2005Aventis Pharmaceuticals Inc., Axys Pharmaceuticals, Inc.Compounds and compositions as cathepsin S inhibitors
    US-7030116-B2April 18, 2006Aventis Pharmaceuticals Inc., Axys Pharmaceuticals, Inc.Compounds and compositions as cathepsin inhibitors
    US-7148349-B2December 12, 2006Metabasis Therapeutics, Inc.Cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs
    US-7151092-B2December 19, 2006Metabasis Therapeutics, Inc.Cytarabine monophosphate prodrugs
    US-7193081-B2March 20, 2007Metabasis Therapeutics, Inc.Process for preparation of cyclic prodrugs of PMEA and PMPA
    US-7196099-B2March 27, 2007Aventis Pharmaceuticals Inc., Axys Pharmaceuticals Inc.Compounds and compositions as cathepsin inhibitors
    US-7205404-B1April 17, 2007Metabasis Therapeutics, Inc.Phosphorus-containing prodrugs
    US-7214668-B2May 08, 2007Metabasis Therapeutics, Inc.Phosphonic acid based prodrugs of PMEA and its analogues
    US-7351399-B2April 01, 2008Metabasis Therapeutics, Inc.Prodrugs for phosphorus-containing compounds
    US-7459461-B2December 02, 2008Ortho-Mcneil Pharmaceutical, Inc.Phosphonic acid compounds as inhibitors of serine proteases
    US-7498320-B2March 03, 2009Metabasis Therapeutics, Inc.Cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs
    US-7553826-B2June 30, 2009Metabasis Therapeutics, Inc.Cytarabine monophosphate prodrugs
    US-7582758-B2September 01, 2009Metabasis Therapeutics, Inc.Lewis acid mediated synthesis of cyclic esters
    US-7704958-B1April 27, 2010Bio Holding, Inc.Methods and compositions for inhibiting apoptosis using serine protease inhibitors
    US-7816345-B2October 19, 2010Metabasis Therapeutics, Inc.Phosphorus-containing prodrugs
    US-8071551-B2December 06, 2011BioHolding, Inc.Methods and compositions for treating diabetes
    US-8080536-B2December 20, 2011Metabasis Therapeutics, Inc.Phosphorus-containing prodrugs
    US-8178673-B2May 15, 2012Ortho-Mcneil Pharmaceutical, Inc.Phosphonic acid compounds as inhibitors of serine proteases
    US-8198440-B2June 12, 2012Ortho-Mcneil Pharmaceutical, Inc.Phosphonic acid compounds as inhibitors of serine proteases
    US-8207338-B2June 26, 2012Ortho-Mcneil Pharmaceutical, Inc.Phosphonic acid compounds as inhibitors of serine proteases
    US-8212039-B2July 03, 2012Ortho-Mcneil Pharmaceutical, Inc.Phosphonic acid compounds as inhibitors of serine proteases
    US-8247599-B2August 21, 2012Ortho-Mcneil Pharmaceutical, Inc.Phosphonic acid compounds as inhibitors of serine proteases
    US-8304430-B2November 06, 2012Ortho-Mcneil Pharmaceutical, Inc.Phosphonic acid compounds as inhibitors of serine proteases
    US-8394804-B2March 12, 2013Janssen Pharmaceutica N.V.Phosphonic acid compounds as inhibitors of serine proteases
    US-8461195-B2June 11, 2013Janssen Pharmaceutica N.V.Phosphonic acid compounds as inhibitors of serine proteases
    US-8497373-B2July 30, 2013Ortho-Mcneil Pharmaceutical, Inc.Phosphonic acid compounds as inhibitors of serine proteases
    US-8609888-B2December 17, 2013Ortho-Mcneil Pharmaceutical, Inc.Phosphonic acid compounds as inhibitors of serine proteases
    US-8664195-B2March 04, 2014Metabasis Therapeutics, Inc.Phosphorus-containing prodrugs
    US-8703957-B2April 22, 2014Janssen Pharmaceutica NvPhosphonic acid compounds as inhibitors of serine proteases
    WO-0055124-A2September 21, 2000Axys Pharmaceuticals, Inc.Composes et compositions utilises comme inhibiteurs de protease
    WO-0055124-A3August 16, 2001Axys Pharm Inc, Ann M Buysse, Rohan V Mendonca, James T Palmer, Tian Zong Qiang, Shankar VenkatramanNovel compounds and compositions as protease inhibitors
    WO-03035654-A1May 01, 2003Ortho-Mcneil Pharmaceutical, Inc.Composes d'acide phosphonique utilises comme inhibiteurs de serine proteases
    WO-9945016-A2September 10, 1999Metabasis Therapeutics, Inc.Nouveaux promedicaments pour composes contenant du phosphore
    WO-9945016-A3June 15, 2000Metabasis Therapeutics IncNouveaux promedicaments pour composes contenant du phosphore